Abstract
In recent years policymakers in a number of American states have chosen biotechnology as a key element in their economic development efforts. With visions of business growth and new jobs, state officials have targeted biotechnology as an important industry of the future. In this paper we focus on the political dynamics that underlay the choice of biotechnology in eleven states. With those states providing examples, we identify three major models of policy choice. The first involves an interest-based process in which state policymakers respond to explicit or implicit pressures from different parties. The second involves a strategic planning exercise in which state officials analyze the economic structure of the state and seek to develop a comparative advantage in the field of biotechnology. And the third starts with a strategic analysis but then relies upon a competitive, interest-based process to determine the allocation of state funds. We conclude by briefly discussing major issues for science policymaking at the state level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
